+ 1 888 391 5441

The Future of the Osteoporosis Drug Market


Osteoporosis is a disease that causes bones to become brittle and weak. People suffering from osteoporosis are at an increased risk of having fractures. As there are no symptoms of the disease at the early stage, osteoporosis is quite difficult to diagnose. Some of the symptoms of osteoporosis include stooped posture, back pain, loss of height and fractures that occur more easily. Although osteoporosis affects people of all ages, sex and races, people of Asian and European descent are at a higher risk of developing the disease. Women, particularly those who are past menopause are also more likely to develop osteoporosis. There are two types of osteoporosis medication that are typically given to patients. These are anabolic drugs that are responsible for increasing the rate of bone formation and antiresorptive medication that slows down the rate of bone loss.

The worldwide market for osteoporosis drug was valued at 7.3 billion USD in 2010. It is estimated to have a compound annual growth rate of 9.2% during the period from 2010 to 2015 and is forecasted to reach a value of 11.4 billion by the year 2015. China has emerged as the leading producer of osteoporosis drug and by the year 2015, the market will be worth 2.5 billion USD. From 2010 to 2015, the annual growth rate in the Chinese osteoporosis drug market is expected to be 13.5%. The rapid growth in the osteoporosis drug industry in China is due to the increase in the number of Chinese women developing the disease. Other factors that are influencing the growth of the industry are increase in population, rise in elderly population and growing awareness about osteoporosis. As the standard of living in China has risen, more and more people are becoming aware about bone health. In the last 30 years, there has been a 300% increase in the number of people developing osteoporosis in China.

The market for osteoporosis drug can be divided into five segments; bisphosphonate drugs, parathyroid hormone drugs, denosumab drugs, SERM drugs and calcitonin drugs. Of these, the sale of biophosphonate drugs dominates the market. In the coming years, with research and development in new drugs and advanced clinical trials, the market for osteoporosis drugs is predicted to boom.

Explore the latest market research report on osteoporosis drug industry @ http://www.chinamarketresearchreports.com/114662.html.

Why http://www.chinamarketresearchreports.com
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy